BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33653965)

  • 21. Salidroside Induces Apoptosis in Human Gastric Cancer Cells via the Downregulation of ENO1/PKM2/GLUT1 Expression.
    Dai Z; Zhang X; Li W; Tang J; Pan T; Ma C; Guan Q
    Biol Pharm Bull; 2021 Nov; 44(11):1724-1731. PubMed ID: 34471002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Signalling Cross-Talk between Cancer Cells and Cancer-Associated Fibroblast through Monocarboxylate Transporters in Head and Neck Cancer.
    Chandel V; Kumar D
    Anticancer Agents Med Chem; 2021; 21(11):1369-1378. PubMed ID: 32698754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential Expression of Glycolysis-Related Proteins in Follicular Neoplasms versus Hürthle Cell Neoplasms: A Retrospective Analysis.
    Kim HM; Koo JS
    Dis Markers; 2017; 2017():6230294. PubMed ID: 28790533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis.
    Gao P; Shen S; Li X; Liu D; Meng Y; Liu Y; Zhu Y; Zhang J; Luo P; Gu L
    Drug Des Devel Ther; 2020; 14():2091-2100. PubMed ID: 32546972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of glycolysis markers in pancreatic cancer: A systematic review and meta-analysis.
    Wang C; Xu R; Song J; Chen Y; Yin X; Ruze R; Xu Q
    Front Oncol; 2022; 12():1004850. PubMed ID: 36172154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic and predictive value of excision repair cross-complementation group 1 (ERCC1) protein in 1288 patients with head and neck squamous cell carcinoma treated with platinum-based therapy: a meta-analysis.
    Bišof V; Zajc Petranović M; Rakušić Z; Samardžić KR; Juretić A
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2305-17. PubMed ID: 26179868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and clinical significance of pyruvate kinase M2 in breast cancer: A protocol for meta-analysis and bioinformatics validation analysis.
    Li H; Yan M; Wu X; Wang Y; Huang L
    Medicine (Baltimore); 2021 May; 100(18):e25545. PubMed ID: 33950928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
    Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.
    Ambrosetti D; Dufies M; Dadone B; Durand M; Borchiellini D; Amiel J; Pouyssegur J; Rioux-Leclercq N; Pages G; Burel-Vandenbos F; Mazure NM
    PLoS One; 2018; 13(2):e0193477. PubMed ID: 29481555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review.
    Ipenburg NA; Koole K; Liem KS; van Kempen PM; Koole R; van Diest PJ; van Es RJ; Willems SM
    Target Oncol; 2016 Feb; 11(1):17-27. PubMed ID: 26115874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis.
    Cao YW; Liu Y; Dong Z; Guo L; Kang EH; Wang YH; Zhang W; Niu HT
    Urol Oncol; 2018 Jun; 36(6):311.e15-311.e25. PubMed ID: 29657088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The expression of PKM2 and HIF-1α in laryngeal squamous cell carcinoma and its clinical indication].
    Liu X; Shan C; Xu O; Wang J; Zhang H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jul; 29(13):1152-5. PubMed ID: 26540912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic value of Tiam1 protein expression in head and neck squamous cell carcinoma: a retrospective study.
    Yang H; Cai YC; Cao Y; Song M; An X; Xia Y; Wei J; Jiang WQ; Shi YX
    Chin J Cancer; 2015 Sep; 34(12):614-21. PubMed ID: 26369827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration.
    Gao HJ; Zhao MC; Zhang YJ; Zhou DS; Xu L; Li GB; Chen MS; Liu J
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1151-62. PubMed ID: 25446815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis.
    Zhou C; Shen Z; Ye D; Li Q; Deng H; Liu H; Li J
    Cell Physiol Biochem; 2018; 50(3):868-882. PubMed ID: 30355925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocarboxylate transporter-1 (MCT1) protein expression in head and neck cancer affects clinical outcome.
    Leu M; Kitz J; Pilavakis Y; Hakroush S; Wolff HA; Canis M; Rieken S; Schirmer MA
    Sci Rep; 2021 Feb; 11(1):4578. PubMed ID: 33633176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycolysis-related protein expression in thyroid cancer.
    Nahm JH; Kim HM; Koo JS
    Tumour Biol; 2017 Mar; 39(3):1010428317695922. PubMed ID: 28347233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic molecular markers in head and neck squamous cell carcinoma in a New Zealand population: matrix metalloproteinase-2 and sialyl Lewis x antigen.
    Gunawardena I; Arendse M; Jameson MB; Plank LD; Gregor RT
    ANZ J Surg; 2015 Nov; 85(11):843-8. PubMed ID: 24171785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.
    Sáenz-de-Santa-María I; Bernardo-Castiñeira C; Secades P; Bernaldo-de-Quirós S; Rodrigo JP; Astudillo A; Chiara MD
    Oncotarget; 2017 Feb; 8(8):13730-13746. PubMed ID: 28099149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.